Compare RBA & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RBA | WST |
|---|---|---|
| Founded | 1958 | 1923 |
| Country | United States | United States |
| Employees | 8000 | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7B | 18.5B |
| IPO Year | N/A | 2004 |
| Metric | RBA | WST |
|---|---|---|
| Price | $104.92 | $294.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $122.20 | ★ $325.86 |
| AVG Volume (30 Days) | ★ 961.8K | 865.5K |
| Earning Date | 05-04-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.18% | 0.30% |
| EPS Growth | N/A | ★ 1.49 |
| EPS | N/A | ★ 1.92 |
| Revenue | N/A | ★ $2,886,900,000.00 |
| Revenue This Year | $4.43 | $6.76 |
| Revenue Next Year | $6.65 | $6.22 |
| P/E Ratio | ★ $52.68 | $151.68 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $93.58 | $203.74 |
| 52 Week High | $119.58 | $322.34 |
| Indicator | RBA | WST |
|---|---|---|
| Relative Strength Index (RSI) | 58.11 | 66.05 |
| Support Level | $95.05 | $257.29 |
| Resistance Level | $106.01 | $322.34 |
| Average True Range (ATR) | 2.41 | 8.47 |
| MACD | 0.44 | 2.47 |
| Stochastic Oscillator | 64.24 | 62.06 |
RB Global has evolved into a leading global marketplace that connects buyers and sellers of commercial assets and vehicles. It is the result of the 2023 combination of Ritchie Bros. and IAA. Ritchie Bros.' roots were as an auctioneer facilitating transactions of commercial, construction, and transportation equipment (excavators, bulldozers, forklifts, and commercial trucks and trailers). However, it has evolved into an omnichannel marketplace. IAA has similar roots, though primarily focused on the salvage auction segment for consumer automobiles. The group provides ancillary services including title processing, transportation/towing, financing, data and appraisal, and so on. Its activities are international, though skewing approximately two-thirds to North America.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.